The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.755
Bid: 4.71
Ask: 4.80
Change: 0.00 (0.00%)
Spread: 0.09 (1.911%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.755
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

29 Mar 2012 07:00

RNS Number : 2938A
Seeing Machines Limited
29 March 2012
 



 

 

 

Seeing Machines Limited

("Seeing Machines" or the "Company")

 

INTERIM RESULTS FOR THE SIX MONTHS TO 31 DECEMBER 2011

 

Seeing Machines Limited (AIM: SEE), a leading developer of facial image processing software for applications that rely on understanding the movement of human faces and eyes, announces its interim results for the six months to 31 December 2011.

Financial Highlights

·; Revenue for the half year to 31 December 2011 of A$3,794,960 (2010 - A$4,019,515);

o Revenue from customers in Australia up 464% to A$942,057 (2010 - A$165,807);

·; Net loss of A$936,801 for the half year to 31 December 2011 (2010 - A$748,934); and

·; Cash and cash equivalents of A$1,070,433 (2010 - A$1,648,786).

Operational Highlights

·; Revitalisation of leadership with the appointment of Ken Kroeger as CEO in July 2011 and subsequently Managing Director from January 2012;

·; Completion of the development of the DSS-IVS3 ruggedized hardware version;

·; Continued expansion of the DSS pipeline with new and existing customers across all regions;

·; New partnership opportunities identified for the DSS which will expand our routes to market;

·; Successful introduction of new service offerings for the DSS, further enhancing our overall value proposition and diversifying revenue opportunities;

·; Development of the next generation of our precision gaze Eye Tracking technology;

·; Progressing opportunities for faceAPI licensing , which could generate significant revenue;

·; New production licenses for faceAPI including Spatial View and Monster Media;

·; Significant progress of the TrueField analyser for additional disease coverage; and

·; Subsequent to the period end, DSS version 3 launched in January 2012 along with new services enabled by the DSSi platform.

Outlook

The directors are confident that the Company will see revenue growth across the DSS and API businesses and that this will provide a strong foundation for the remainder of 2012 and into 2013.

Ken Kroeger, Managing Director and CEO of Seeing Machines said:

"The first half of FY2012, whilst down on revenue compared to the prior year, actually represents a sequential increase over the previous half. It's particularly pleasing to see the growth of the DSS business in Australia and the revenue that has resulted from that. We expect that in this current period, a number of opportunities will be converted and that we will continue on our growth trajectory."

Extracts from the interim financial statements are set out below and a full copy is available from the Company website www.seeingmachines.com and is also available by request to the Company's Registered Office at Level 1, 11 Lonsdale St Braddon ACT 2612, Australia.

Enquiries:

 

Seeing Machines Limited

Ken Kroeger, Managing Director CEO

+61 (2) 6103 4700

Daniel Stewart & Company plc

David Hart/James Thomas

+44 (0) 20 7776 6550

Walbrook PR Ltd

Paul Cornelius

Helen Westaway

+44 (0) 20 7933 8780

+44 (0) 7827 879 460 or paul.cornelius@walbrookir.com

+44 (0) 7866 384 707 or helen.westaway@walbrookpr.com

DIRECTORS' REPORT EXTRACT

Review of the first half of the 2012 financial year

 

The Company achieved revenues of A$3,048,410 from the sale of goods and services and A$746,550 from other income resulting in total revenue for the half year to 31 December 2011 of A$3,794,960 (2010: A$4,090,515).

 

The first six months of the 2012 financial year were slow in comparison to the corresponding period in 2011. It should be noted that in 2011 the Company had A$1 million in orders at the start of the period due to the rollout of the DSS to Freeport-McMoRan sites in North America.

 

The Company made a net loss of A$936,801 for the six months to 31 December 2011 compared to a net loss of A$748,934 for the period to 31 December 2010.

 

Operational highlights for the half-year include:

 

·; Revitalisation of leadership with the appointment of Ken Kroeger as CEO in July 2011 and Managing Director from January 2012;

·; Completion of the DSS 3 ruggedized hardware version;

·; Continued growth of the DSS pipeline with new customers and expansion at existing sites across customers and regions;

·; New partnership opportunities for the DSS which will increase channels to market;

·; Introduction of new services offerings for the DSS enhancing our overall DSS offering and diversifying revenue opportunities;

·; The expansion of our clientele in Australia as evidenced by the revenue of A$942,057 compared to A$165,807 for the corresponding period in 2010;

·; Development of the next generation of our precision gaze Eye Tracking technology;

·; Opportunities for faceAPI licensing being progressed which will generate significant revenue;

·; New production licenses for faceAPI including Spatial View and Monster Media; and

·; TrueField progress and potential for additional disease coverage.

 

Financial Results

 

The Company achieved revenues of A$3,048,410 (2010: A$4,019,515) from the sale of goods and services and A$746,550 (2010: A$70,932) from other income resulting in total revenue for the half year to 31 December 2011 of A$3,794,960 (2010: A$4,090,515). The substantial increase in other income is due to the Company receiving a R&D Tax Offset for its Research &Development relating to the 2010 financial year.

 

Revenue for the half year for each of the three products; DSS, faceAPI and faceLAB compared to the same period last year is shown in the following table.

 

 

Product

31 December 2011

31 December 2010

Variance

DSS

1,981,396

2,601,968

-24%

faceLAB

861,697

1,197,189

-28%

faceAPI

205,317

220,358

-7%

 

The high value of the Australian dollar against the US, Euro and Great Britain currencies has had a negative impact on revenue earnt from those regions over the period. Cost of sales at A$1,209,167 (2010: A$1,403,134) was down due to lower revenues though was up 4% at 39% of revenue as opposed to 35% of revenue for the corresponding period in 2010. Net expenditure for the half-year was A$3,624,458 up from A$3,436,247 for the period to 31 December 2010. Costs in the period have been tightly controlled to preserve cash and much of the increase relates to non-cash items including the salary sacrifice share arrangement under the Executive Share Plan.

 

The net loss for the six months to 31 December 2011 was A$936,801 compared to a net loss of A$748,934 for the period to 31 December 2010.

 

Cash at 31 December 2011 was A$1,070,433 compared to A$2,478,641 at 31 December 2010.

 

 

Operational Highlights

 

DSS

 

DSS achieved revenue of A$1,981,396 for the six months to 31 December 2011, down from A$2,601,968 achieved for the six months to 31 December 2010. However, this revenue was up 17% sequentially from the second half of the year ending 30 June 2011. Revenue was generated from:

 

·; sales of DSS units;

·; software licensing;

·; installation services;

·; maintenance and support fees;

·; field support services; and

·; DSSi services including event classification and reporting services.

 

We have seen growth in the customer base and diversification in revenue types generated by the DSS which provides a solid foundation for recurring revenue into the future.

 

Revenue came from a number of existing and new customers, and from locations in North and South America, Africa, Australia, Mongolia and Indonesia. Notably we saw a significant expansion in sites in Australia and we now have several installations in Queensland and Western Australia across a number of customers. This includes Toll Mining Services with four sites, two in Queensland and two in WA. As a result, there has been significant growth in Australian derived revenue to A$965,807 for the half year to 31 December 2011 an increase of 468% over the corresponding period in 2010 and almost entirely due to these DSS sales.

 

The Company has recently relocated its Queensland team to larger premises to accommodate the growth and the Arizona team will relocate to larger premises this month in order to offer a full service, inventory storage and maintenance facility for the DSS platform across the Americas.

 

A number of opportunities for alternate ways to bring the DSS to market are also being pursued. These opportunities include mining, on the road transport and OEM opportunities for the wider automotive market.

 

In terms of R&D. the major advance has been the completion of the development for the new DSS-IVS 3 - the ruggedized hardware version for the mining industry. This new product is designed for the harshest of environments and we expect this version to lead to an expansion in roll-outs with existing customers and faster uptake of the product elsewhere.

 

DSS version 3 was launched in January 2012 along with new services offerings for the DSS enabled by the DSSi platform.

 

For the remainder of this financial year we will focus our energies on expansion of the DSS business through:

 

·; closing a number of significant deals that will further entrench the DSS as the superior product for the mining industry;

·; delivering, installing and supporting customers implementing DSS in their businesses;

·; further build the DSS team to support our customers in their use of the product;

·; further R&D aimed at keeping the technology ahead of its competitors, expand the markets we can target and incorporating feedback and features that our existing customers need; and

·; Progressing the partnership opportunities that will expand our routes to market.

 

 

faceAPI

 

faceAPI achieved revenue of A$205,317 (2010: A$220,358) for the six months to 31 December 2011.

 

The Company has signed additional production license deals for faceAPI with Spatial View and Monster Media which deliver annual royalties to Seeing Machines. The Company is progressing faceAPI licensing opportunities with significant ongoing royalty streams which will support this part of the business and provide resources to support ongoing investment in research and development of the core technology platform.

 

The Company is currently developing the next generation of its gaze technology which will support existing and future products and which will provide further options for monetising the technology across numerous applications and delivery platforms.

 

The Directors believe that the Company is well placed with faceAPI to take advantage of the many opportunities that will arise now that EyeTracking has progressed from the limited province of researchers and into mainstream.

 

 

faceLAB

 

faceLAB achieved revenue of A$861,697 (2010: A$1,197,189) for the six months to 31 December 2011, a reduction of 28% over the six months to 31 December 2010.

 

The Company is working with its partner EyeTracking Inc on the next generation of its offering for the EyeTracking research market. The precision gaze technology mentioned above will also feature in this new offering.

 

 

TrueField

 

The Company's focus continues to be to support the work of our partners at the Australian National University (ANU) who are refining and proving the scientific methods on which the product is based. Indications are that results will be known during the latter half of the 2012 calendar year.

 

The ANU researchers believe that the product will have applicability beyond glaucoma the initial eye disease targeted.

 

Statement of Financial Position

Consolidated

31 DEC 2011

30 JUN 2011

AS AT 31 DECEMBER 2011

Note

A$

A$

ASSETS

CURRENT ASSETS

Cash and cash equivalents

 

1,070,433

1,648,786

Trade and other receivables

 

1,503,948

1,555,275

Inventories

230,045

332,152

Other current assets

188,097

199,341

TOTAL CURRENT ASSETS

2,992,523

3,735,554

NON-CURRENT ASSETS

Property, plant and equipment

307,314

358,900

Intangible assets

474,917

467,582

TOTAL NON-CURRENT ASSETS

782,231

826,482

TOTAL ASSETS

3,774,754

4,562,036

LIABILITIES

CURRENT LIABILITIES

Trade and other payables

1,267,868

1,325,671

Provisions

402,725

402,129

TOTAL CURRENT LIABILITIES

1,670,593

1,727,800

NON-CURRENT LIABILITIES

Provisions Non-Current

163,628

159,754

TOTAL NON-CURRENT LIABILITIES

163,628

159,754

TOTAL LIABILITIES

1,834,221

1,887,554

NET ASSETS

1,940,533

2,674,482

EQUITY

Contributed equity

15,024,112

14,813,612

Accumulated losses

(13,769,184)

(12,832,383)

Other reserves

685,605

693,253

TOTAL EQUITY

1,940,533

2,674,482

 

The above statement of financial position should be read in conjunction with the accompanying notes.

 

Statement of Comprehensive Income

Consolidated

2011

2010

FOR THE HALF-YEAR ENDED 31 December 2011

Note

A$

A$

Continuing operations

Sale of goods and licence fees

2,623,901

3,962,495

Rendering of services

424,509

57,020

Revenue

3,048,410

4,019,515

Cost of Sales

(1,209,167)

(1,403,134)

Gross Profit

1,839,243

2,616,381

Other income

 

746,550

70,932

Research and Development Expenses

(607,318)

(1,243,887)

Distribution Expenses

(291,208)

(166,954)

Marketing expenses

(597,348)

(719,497)

Occupancy and facilities expenses

(376,270)

(332,880)

Administration and support expenses

(1,701,382)

(581,591)

Other expenses

 

50,932

(391,438)

Loss before income tax

(936,801)

(748,934)

Income tax expense

-

-

Loss after income tax

(936,801)

(748,934)

Net Loss for the period

(936,801)

(748,934)

Other comprehensive income

Foreign currency translation

(7,648)

(1,009)

Other comprehensive income net of tax

Total comprehensive income

(944,449)

(749,943)

Earnings per share for profit attributable to the ordinary

equity holders of the Company:

·; Basic earnings per share

(0.226)

(0.185)

·; Diluted earnings per share

(0.226)

(0.185)

 

Statement of Changes in Equity

 

Contributed Equity

Accumulated Losses

Foreign Currency Translation

Employee Equity Benefits Reserve

Total Equity

FOR THE HALF-YEAR ENDED 31 December 2011

Note

A$

A$

A$

A$

A$

At 1 July 2010

14,664,487

(10,657,432)

46,905

780,229

4,834,189

Loss for the half-year

-

(748,934)

-

-

(748,934)

Other comprehensive income

-

-

(1,009)

-

(1,009)

Total comprehensive income

-

(748,934)

(1,009)

-

(749,943)

Transaction with owner in their capacity as owner

Share based payment

-

-

-

(54,582)

(54,582)

At 31 December 2010

14,664,487

(11,406,366)

45,896

725,647

4,029,664

At 1 July 2011

14,813,612

(12,832,383)

44,994

648,259

2,674,482

Loss for the half-year

-

(936,801)

-

-

(936,801)

Other comprehensive income

-

-

(7,648)

-

(7,648)

Total comprehensive income

-

(936,801)

(7,648)

-

(944,449)

Transaction with owner in their capacity as owner

Share issue

210,500

-

-

210,500

At 31 December 2011

15,024,112

(13,769,184)

37,346

648,259

1,940,533

 

Statement of Cash Flows

 

 

Consolidated

 

2011

2010

 

FOR THE HALF-YEAR ENDED 31 December 2011

Note

A$

A$

 

 

Cash flows from operating activities

 

Receipts from customers

3,835,784

3,534,350

 

Payment to suppliers and employees

(4,388,295)

(4,833,816)

 

Interest received

21,747

41,569

 

Net cash flows used in operating activities

(530,764)

(1,257,897)

 

 

Cash flows from investing activities

 

Purchase of plant and equipment

(11,029)

(86,327)

 

Payments for intangible assets

(28,912)

(17,028)

 

Net cash flows used in investing activities

(39,941)

(103,355)

 

 

Net decrease in cash and cash equivalents

(570,705)

(1,361,252)

 

Net foreign exchange differences

(7,648)

(711)

 

Cash and cash equivalents at beginning of period

1,648,786

3,840,604

 

Cash and cash equivalents at end of period

1,070,433

2,478,641

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FMGZFKRZGZZM
Date   Source Headline
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3
9th Jan 20247:00 amRNSSeeing Machines unveils latest Guardian technology
3rd Jan 20247:00 amRNSSeeing Machines to showcase technology at CES 2024
20th Dec 20237:00 amRNSSeeing Machines announces US$30M European OEM win
13th Dec 20238:02 amRNSSeeing Machines welcomes U.S. NHTSA announcement
12th Dec 20237:00 amRNSSeeing Machines Wins Prestigious Road Safety Award
29th Nov 20237:57 amRNSResult of AGM
24th Nov 20237:00 amRNSAGM – reminder and correction of login details
8th Nov 20237:00 amRNS16th Automotive program awarded & Q1 FY2024 KPIs
6th Nov 202311:26 amRNSDirector/PDMR Shareholding
31st Oct 202311:50 amRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSNotice of AGM
27th Oct 20237:19 amRNSDirector/PDMR Shareholding
27th Oct 20237:13 amRNSDirector/PDMR Shareholding
25th Oct 20237:55 amRNSDirector/PDMR Shareholding
25th Oct 20237:00 amRNSBoard Changes
20th Oct 20239:30 amRNSDirector/PDMR Shareholding
20th Oct 20239:21 amRNSDirector/PDMR Shareholding
19th Oct 20238:47 amRNSDirector/PDMR Shareholding
18th Oct 202310:06 amRNSDirector/PDMR Shareholding
17th Oct 20239:41 amRNSDirector/PDMR Shareholding
16th Oct 20237:00 amRNSYear End Results – FY2023
16th Oct 20237:00 amRNSDevelopment of aviation fatigue detection solution
14th Sep 20237:00 amRNSNotice of Full Year Results 2023
7th Sep 20235:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSFY2023 Trading Update & Q4 KPIs
18th Jul 20237:30 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSCEO Incentive Plan
28th Jun 20231:44 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
26th Jun 202311:38 amRNSDirector/PDMR Shareholding
23rd Jun 20238:55 amRNSDirector/PDMR Shareholding
20th Jun 20237:30 amRNSCollaboration with synthetic data specialist
19th Jun 20238:00 amRNSSeeing Machines to attend Stifel Tech Conference
25th May 20239:53 amRNSDirector/PDMR Shareholding
22nd May 20239:46 amRNSDirector/PDMR Shareholding
16th May 20237:00 amRNSExclusive Agreement Signed with Collins Aerospace
4th May 20237:00 amRNSKey Performance Indicators Q3 FY2023
17th Apr 20239:29 amRNSDirector/PDMR Shareholding
13th Apr 202312:36 pmRNSDirector/PDMR Shareholding
11th Apr 202311:15 amRNSPDMR Shareholding
6th Apr 20232:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.